Literature DB >> 14675586

Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy.

Daniel W Isenbarger1, Steven M Kent, Patrick G O'Malley.   

Abstract

Multiple small studies of oral N-acetylcysteine for prevention of contrast nephropathy have been performed, demonstrating variable efficacy. We performed a meta-analysis of the randomized clinical trials to clarify the degree of benefit.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14675586     DOI： 10.1016/j.amjcard.2003.08.059

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  21 in total

Review 1.  Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.

Authors:  Giuseppe G L Biondi-Zoccai; Marzia Lotrionte; Antonio Abbate; Luca Testa; Enrico Remigi; Francesco Burzotta; Marco Valgimigli; Enrico Romagnoli; Filippo Crea; Pierfrancesco Agostoni
Journal:  BMJ       Date:  2006-01-16

Review 2.  [Chronic critical ischemia of the lower leg: pretherapeutic imaging and methods for revascularization].

Authors:  M Treitl; V Ruppert; A K Mayer; C Degenhart; M Reiser; J Rieger
Journal:  Radiologe       Date:  2006-11       Impact factor: 0.635

3.  Efficacy and safety of endovascular therapy by diluted contrast digital subtraction angiography in patients with chronic kidney disease.

Authors:  Naoki Hayakawa; Satoshi Kodera; Noriyoshi Ohki; Junji Kanda
Journal:  Heart Vessels       Date:  2019-04-15       Impact factor: 2.037

Review 4.  Contrast-induced acute kidney injury: short- and long-term implications.

Authors:  Steven D Weisbord; Paul M Palevsky
Journal:  Semin Nephrol       Date:  2011-05       Impact factor: 5.299

5.  N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration.

Authors:  S J Shalansky; G E Pate; A Levin; J G Webb
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

Review 6.  Acute renal failure.

Authors:  John A Kellum; Martine Leblanc; Ramesh Venkataraman
Journal:  BMJ Clin Evid       Date:  2008-09-03

7.  N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.

Authors:  Manouchehr Amini; Mojtaba Salarifar; Alireza Amirbaigloo; Farzad Masoudkabir; Fatemeh Esfahani
Journal:  Trials       Date:  2009-06-29       Impact factor: 2.279

Review 8.  Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.

Authors:  Jeremiah R Brown; Clay A Block; David J Malenka; Gerald T O'Connor; Anton C Schoolwerth; Craig A Thompson
Journal:  JACC Cardiovasc Interv       Date:  2009-11       Impact factor: 11.195

Review 9.  [Contrast induced nephropathy].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 10.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.